Arcutis Biotherapeutics, Inc. (ARQT)
NASDAQ: ARQT · Real-Time Price · USD
13.82
+0.15 (1.10%)
At close: Jun 20, 2025, 4:00 PM
13.88
+0.06 (0.43%)
After-hours: Jun 20, 2025, 7:42 PM EDT
Arcutis Biotherapeutics Market Cap
Arcutis Biotherapeutics has a market cap or net worth of $1.65 billion as of June 20, 2025. Its market cap has increased by 80.59% in one year.
Market Cap
1.65B
Enterprise Value
1.56B
1-Year Change
80.59%
Ranking
Category
Stock Price
$13.82
Market Cap Chart
Since January 31, 2020, Arcutis Biotherapeutics's market cap has increased from $782.04M to $1.65B, an increase of 110.65%. That is a compound annual growth rate of 14.83%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 20, 2025 | 1.65B | 1.04% |
| Dec 31, 2024 | 1.63B | 434.82% |
| Dec 29, 2023 | 304.85M | -66.18% |
| Dec 30, 2022 | 901.45M | -13.58% |
| Dec 31, 2021 | 1.04B | -14.88% |
| Dec 31, 2020 | 1.23B | 56.71% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 686.28B |
| Johnson & Johnson | 360.09B |
| Novo Nordisk | 333.14B |
| AbbVie | 326.93B |
| UnitedHealth Group | 276.70B |
| Abbott Laboratories | 231.21B |
| Novartis AG | 227.73B |
| AstraZeneca | 219.65B |